Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03838900 · ClinicalTrials.gov registry record
The Loop Observational Study
A clinical trial of Diabetes Mellitus, Type 1, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- 1,212
- Enrollment target
- 1
- Study location
NCT03838900 is a study of Diabetes Mellitus, Type 1 that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 1,212 participants, roughly in line with the 1,256-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT03838900, a study of Diabetes Mellitus, Type 1, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- 1,212 participants
- Enrollment target
- 1
- Study location
Study Summary
An observational study to collect data on the efficacy, safety, usability, and quality of life/psychosocial effects of the Loop DIY automated insulin delivery system.
Conditions Studied
Interventions
- DEVICE Loop
Study Locations (1)
Florida
- Jaeb Center for Health Research - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,212 participants |
| Start Date | 2019-01-17 |
| Est. Completion | 2020-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03838900
The ClinicalTrials.gov registry entry for NCT03838900 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,212 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,256-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Loop is the first listed.
NCT03838900 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03838900 about?
NCT03838900 is a clinical study titled "The Loop Observational Study". An observational study to collect data on the efficacy, safety, usability, and quality of life/psychosocial effects of the Loop DIY automated insulin delivery system.
What is the current status of trial NCT03838900?
This trial is currently completed. The enrollment target is 1,212 participants. The study started on 2019-01-17. Estimated completion is 2020-04-25.
What conditions does trial NCT03838900 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT03838900?
The interventions under investigation include: Loop (DEVICE).
Who is sponsoring clinical trial NCT03838900?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03838900 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
RECRUITING · Phase 2
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.